Market Research Engine has published a new report titled as “Pain Management Drugs Market Size By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2019-2025.”
Browse Full Report:https://www.marketresearchengine.com/pain-management-drugs-market
Pain management is one among the branch of drugs which utilizes an inter punitive approach for improving the prevalence and easing the suffering of lifetime of persons who live with the chronic pain. Pain may be a distressing sensory and emotional feeling, which occurs thanks to tissue damage or illness. additionally, various diseases, like MS, osteoarthritis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer can cause pain.
The duration of pain varies from short term referred to as acute pain to future referred as chronic pain. Acute pain may be a sudden onset of pain, whereas chronic pain occurs thanks to aging conditions of bone & joints, nerve damage, or injury. The management of pain involves decrease or treatment of pain employing a particular set of medicine. Several drugs are available which give pain relief through a spread of physiological mechanism, like by targeting the nociceptors.
The global Pain Management Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Pain Management Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
The global Pain Management Drugs market is segregated on the basis of Drug Class as NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Nonnarcotic Analgesics. Based on Indication the global Pain Management Drugs market is segmented in Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, and Fibromyalgia.
Pain management is one among the branch of drugs which utilizes an inter punitive approach for improving the prevalence and easing the suffering of lifetime of persons who live with the chronic pain.
The report covers:Global Pain Management Drugs market sizes from 2015 to 2024, along with CAGR for 2018-2024 Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024 Global Pain Management Drugs market trends, covering comprehensive range of consumer trends & manufacturer trends Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Pain Management Drugs market Major market opportunities and challenges in forecast timeframe to be focused Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management Comprehensive company profiles of the key industry players
Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc., and others are among the major players in the global Pain Management Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Pain Management Drugs Market has been segmented as below:
Pain Management Drugs Market, By Drug ClassNSAIDs Anesthetics Anticonvulsants Antimigraine Agents Antidepressants Opioids Tramadol Hydrocodone Oxycodone Others Nonnarcotic Analgesics
Pain Management Drugs Market, By IndicationArthritic Pain Neuropathic Pain Cancer Pain Chronic Back Pain Postoperative Pain Migraine Fibromyalgia
Pain Management Drugs Market, By RegionNorth America Europe Asia-Pacific Rest of the World
Pain Management Drugs Market, By CompanyNovartis AG Eli Lilly & Company Abbott Laboratories Endo Health Solutions, Inc. Purdue Pharma L.P. Pfizer, Inc. F. Hoffmann La Roche Ltd. Merck & Co. Inc. Johnson & Johnson GlaxoSmithKline Plc. Depomed, Inc. Mallinckrodt Pharmaceuticals Teva Pharmaceutical Industries Ltd. AstraZeneca plc. Merck & Co., Inc. GlaxoSmithKline plc.
The global Pain Management Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Pain Management Drugs market share. Major industry players with significant revenue share include Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc., and others.
Reasons to Buy this Report:Gain detailed insights on the Pain Management Drugs industry trends Find complete analysis on the market status Identify the Pain Management Drugs market opportunities and growth segments Analyse competitive dynamics by evaluating business segments & product portfolios Facilitate strategy planning and industry dynamics to enhance decision making
Customized report as per the requirement can be offered with appropriate recommendations
Request Sample Report from here:https://www.marketresearchengine.com/pain-management-drugs-market
Table of Contents:Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary Market Overview
4.2 Porter’s Five Force Analysis
5. Pain Management Drugs Market, By Drug Class
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Antimigraine Agents
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Nonnarcotic Analgesics
5.8.1 Market Overview
5.8.2 Market Size and Forecast
6. Pain Management Drugs Market, By Indication
6.2 Arthritic Pain
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Neuropathic Pain
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Cancer Pain
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Chronic Back Pain
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Postoperative Pain
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8.1 Market Overview
6.8.2 Market Size and Forecast
7. Pain Management Drugs Market, By Geography
7.2 North America
7.2.1 North America Pain Management Drugs, By Drug Class
7.2.2 North America Pain Management Drugs, By Indication
7.3.1 Europe Pain Management Drugs, By Drug Class
7.3.2 Europe Pain Management Drugs, By Indication
7.4.1 Asia-Pacific Pain Management Drugs, By Drug Class
7.4.2 Asia-Pacific Pain Management Drugs, By Indication
7.5 Rest of the World
7.5.1 Rest of the World Pain Management Drugs, By Drug Class
7.5.2 Rest of the World Pain Management Drugs, By Indication
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9. Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
9.1 Novartis AG
9.2 Eli Lilly & Company
9.3 Abbott Laboratories
9.4 Endo Health Solutions, Inc.
9.5 Purdue Pharma L.P.
9.6 Pfizer, Inc.
9.7 F. Hoffmann La Roche Ltd.
9.8 Merck & Co. Inc.
9.9 Johnson & Johnson
9.10 GlaxoSmithKline Plc.
9.11 Depomed, Inc.
9.12 Mallinckrodt Pharmaceuticals
9.13 Teva Pharmaceutical Industries Ltd.
9.14 AstraZeneca plc.
9.15 Merck & Co., Inc.
9.16 GlaxoSmithKline plc.
Other Related Market News :
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States